|
Resolution: standard / high Figure 2.
DFS curves and P-values (log-rank test) for comparisons among patients with no residual tumour (Group
I), those with BMI1-negative tumours (Group II), patients with no residual tumour
and those with BMI1-negative tumours combined (Group I+II), and patients with BMI1-positive
tumours (Group III).
Yoshikawa et al. BMC Cancer 2012 12:461 doi:10.1186/1471-2407-12-461 |
